ICMR allows private Hospital try to plasma therapy Treatment of Covid19 in Bengaluru
plasma therapy |
- A city-based private hospital in Bengaluru has been given nod by ICMR to conduct clinical trials on Covid-19 patients using plasma therapy
- The permission was granted on Monday under the provisions of New Drugs and Clinical Trial Rules, 2019
- This was stated by the Drugs Controller General of India in a letter to HCG Bangalore Institute of Oncology Speciality Centre
Aprivate hospital in Bengaluru has been given the nod by the Indian Council of Medical Research (ICMR) to conduct clinical trials on Covid-19 patients using plasma therapy.
This was stated by the Drugs Controller General of India in a letter to HCG Bangalore Institute of Oncology Speciality Centre.
The permission was granted on Monday under the provisions of New Drugs and Clinical Trial Rules, 2019.
"Grant of permission given to conduct a clinical study in India entitled "Open-label, parallel arm, Phase I/II Clinical Trial to evaluate safety and efficacy of Convalescent plasma as therapy for COVID-19 Severe SARS-Cov-2 Disease," DCGI Dr V G Somani said in the letter.
Sharing the letter on his Twitter handle, the Minister for Medical Education, Dr K Sudhakar, who himself is a medical professional, wrote, "Plasma therapy holds great promise in treating Covid-19 patients and I am happy to inform ICMR agreed to our request and has given permission for plasma treatment to Dr. Vishal Rao, HCG Bangalore Inst of Oncology."
Sharing the letter on his Twitter handle, the Minister for Medical Education, Dr K Sudhakar, who himself is a medical professional, wrote, "Plasma therapy holds great promise in treating Covid-19 patients and I am happy to inform ICMR agreed to our request and has given permission for plasma treatment to Dr. Vishal Rao, HCG Bangalore Inst of Oncology."
WHAT IS CONVALESCENT PLASMA THERAPY?
The convalescent plasma therapy aims at using antibodies from the blood of a recovered Covid-19 patient to threat those critically affected by the virus. The therapy can also used to immunise those at a high risk of contracting the virus -- such as health workers, families of patients and other high-risk contacts.
This therapy's concept is simple and is based on the premise that the blood of a patient who has recovered from Covid-19 contains antibodies with the specific ability of fighting novel coronavirus. . The theory is that the recovered patient's antibodies, once ingested into somebody under treatment, will begin targetting and fighting the novel coronavirus in the second patient.
The convalescent plasma therapy is akin to passive immunisation as, according to researchers, it is a preventive measure and not a treatment for the Covid-19 disease.
Comments